SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 04, 2020 — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines.
( read original story …)
The Taiwan NEWS
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 04, 2020 — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines.
( read original story …)